FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals North America Vaseretic Recall

Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Oct 22, 2014
Recall ID
D-0018-2015
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Vaseretic starting May 21, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0018-2015 on Oct 22, 2014. Reason: Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset

Product description

Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada

Lot numbers, UPCs & expiration codes

VASERETIC 10-25MG TAB 100CT Lot # 12J022P exp. 9/30/2014 VASERETIC 10-25MG TAB 100CT Lot # 13G047P exp. 07/31/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0018-2015
Classification
Class III
Status
Terminated
Recall initiated
May 21, 2014
FDA report date
Oct 22, 2014
Quantity
205,853 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0018-2015, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
68572
Address
400 Somerset Corporate Blvd
Code information
VASERETIC 10-25MG TAB 100CT Lot # 12J022P exp. 9/30/2014 VASERETIC 10-25MG TAB 100CT Lot # 13G047P exp. 07/31/2015
Postal code
08807
Report date
Oct 22, 2014
Product type
Drugs
Recall number
D-0018-2015
Classification
Class III
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
205,853 bottles
Termination date
Aug 4, 2015
Reason for recall
Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada
Distribution pattern
Nationwide
Recall initiation date
May 21, 2014
Initial firm notification
Letter
Center classification date
Oct 10, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0018-2015, published Oct 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls